News

Connect Biopharma to Highlight Innovations at September Conferences

Connect Biopharma to Highlight Innovations at September Conferences

Connect Biopharma's Upcoming Investor Engagements

Connect Biopharma Holdings Limited (NASDAQ: CNTB), a prominent clinical-stage biopharmaceutical company focusing on improving the treatment landscape for inflammatory diseases, has exciting news regarding its participation in two key investor conferences. These conferences provide an excellent platform for the Company to connect with investors and share valuable insights about its ongoing projects and innovations in the healthcare sector.

Cantor Global Healthcare Conference

An Insightful Fireside Chat

As part of its conference schedule, Connect Biopharma will participate in the Cantor Global Healthcare Conference. This event is set for September 3, 2025, at 3:20 p.m. ET. Attendees can look forward to a dynamic fireside chat format, allowing for an interactive dialogue about the Company’s vision and product pipeline.

H.C. Wainwright 27th Annual Global Investment Conference

Following the Cantor Conference, Connect Biopharma will also be featured at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 9:30 a.m. ET. This conference promotes a rich environment for networking and learning about cutting-edge advancements in biopharmaceuticals, particularly in areas involving asthma and COPD management.

Accessing Live Presentations

For those interested in following along, live access to the webcasts of these important presentations will be made available via the Investors section of the Connect Biopharma website. Archived recordings will also be provided for approximately 90 days after each conference, ensuring that investors can revisit these discussions at their convenience.

Company Overview

Founded to revolutionize treatment approaches for chronic diseases, Connect Biopharma is currently advancing rademikibart, a next-generation monoclonal antibody targeting IL-4R?. This innovative therapy is undergoing global clinical trials aimed at addressing significant unmet needs in asthma and COPD. Additionally, the Company holds an exclusive collaboration with Simcere in China, further emphasizing its commitment to expanding access to critical treatments.

Contact Information

For additional inquiries, interested parties can reach out to:

Investor Relations Contact:
Alex Lobo
Precision AQ
alex.lobo@precisionaq.com
(212) 698-8802

Media Contact:
Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
ignacio.guerrero-ros@russopartnersllc.com
(858) 717-2310 or (646) 942-5604

Frequently Asked Questions

What is the purpose of the upcoming conferences for Connect Biopharma?

The upcoming conferences are platforms for Connect Biopharma to present its innovative treatments and engage with potential investors.

When is Connect Biopharma participating in the conferences?

They will participate in the Cantor Global Healthcare Conference on September 3, 2025, and the H.C. Wainwright Conference on September 8, 2025.

How can I access the live presentations from these conferences?

Live presentations will be available through the Investors section of the Connect Biopharma website, along with archived recordings for later access.

What is rademikibart?

Rademikibart is Connect Biopharma’s promising therapy aimed at treating asthma and COPD by targeting the IL-4R? receptor.

Who should I contact for more information?

For investor inquiries, reach Alex Lobo at Precision AQ, and for media inquiries, contact Ignacio Guerrero-Ros at Russo Partners, LLC.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tripadvisor Faces Investigation Over Securities Violations

Updated Category News Views 58

Tripadvisor's Stock Dive: Investor Panic or Opportunity? Woah, if you had a stake in Tripadvisor (NASDAQ: TRIP) recently, you know it hasn't been a walk in the park. Shares took a nosedive of over 20% on November 5, 2026, after they unveiled a frightening $313.1 million net loss for the third quarter. What stirred the pot, you ask? Well, toss in a goodwill impairment...

Continue Reading
D-Wave Faces Lawsuit: Investors Eye Legal Action

Updated Category News Views 102

Securities Lawsuit Shakes D-Wave Quantum Inc. New York's legal corridors are buzzing with news that D-Wave Quantum Inc. (NASDAQ: QBTS) is getting hauled into court over alleged securities law violations. Shareholders who bought into QBTS stock between late February and late August of 2026 now find themselves caught in a lawsuit that's raising eyebrows all around Wall...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 126

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Greenberg Traurig Impresses with High Honors in Florida

Updated Category News Views 113

Legal Powerhouse Garners Accolades You know it's a big deal when a law firm like Greenberg Traurig gets the spotlight at the Florida Legal Luminaries Gala. Held on October 29 in the scenic Key Biscayne, this event was all about recognizing who’s who in the high-stakes world of law. Greenberg Traurig walked away with the 'Best Large Law Firm' award, cementing its stature...

Continue Reading
Netcapital Faces Fraud Lawsuit: Investor Impacts Unravel

Updated Category News Views 42

Investors Caught in Netcapital's Storm Well, here we are, back on the wild roller coaster that is the stock market, and boy, has Netcapital Inc. landed itself in a mess. The company's been hit with a securities fraud class action lawsuit thanks to allegedly cooking up fake consulting agreements that padded their revenues by a cool $14 million. That’s not just pocket...

Continue Reading
Soligenix Holds Steady Amidst Shifting Financial Landscape

Updated Category News Views 7

Stepping into Soligenix's News Every time Soligenix pops up on the radar, it feels like we're watching a biopharma soap opera. This time, they're juggling updates and quarterly numbers that scream both promise and peril. The New Jersey-based company, known for its focus on niche markets with unmet medical needs, tossed out some shiny clinical developments alongside a...

Continue Reading
WebAI Debuts Mac App for On-Device AI Prowess

Updated Category News Views 93

WebAI Breaks the Cloud AI Mold Listen, the tech landscape just got a little more interesting. With webAI's latest move, the game has shifted for those who live and breathe AI but aren't keen on their files dancing across the internet. Their new Mac app lets you run AI models without the cloud's watchful eye—or its per-token charges. Finally, some privacy in this digital...

Continue Reading
Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 6

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
ACT Expands with Broker-Dealer Arm for New Horizons

Updated Category News Views 120

Kicking Open New Doors: ACT's Bold Move Fancy a move with bigger stakes? ACT Capital Advisors just shook the tree, launching a broker-dealer affiliate, ACT Capital Markets. This outfit’s strutting with a brand-new set of services beyond the regular M&A dance, offering capital-raising and financing solutions. It’s not just expanding a portfolio—it’s widening the...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 44

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading

Top 5 Most Recently Viewed Articles

Apollo Global Management's Options Trends and Insights Revealed

Updated Category News Views 230

Understanding Options Trading for Apollo Global Management In the world of finance, significant investors known as "whales" are displaying a notably bearish attitude towards Apollo Global Management. This behavior can be prominent in the options marketplace, where traders are actively expressing their expectations for the stock's future movement. An analysis of the...

Continue Reading
HTX Climbs the Ranks: Establishing Trust in the Web3 Space

Updated Category News Views 208

HTX's Remarkable Ascent in Global Crypto Rankings HTX, a prominent player in the cryptocurrency exchange arena, has recently announced a significant leap in its global standings on major cryptocurrency tracking platforms. This impressive improvement illustrates HTX's growing appeal and solidifies its position as a trusted authority in the international crypto community....

Continue Reading
Rush Enterprises, Inc. Sees Strong Q3 Results and Dividend Declaration

Updated Category News Views 155

Strong Financial Performance by Rush Enterprises, Inc. Rush Enterprises, Inc. (NASDAQ: RUSHA, RUSHB) has released its financial results for the third quarter, highlighting robust revenue streams despite facing some challenges in the commercial vehicle market. The company reported total revenues of approximately $1.9 billion, alongside a net income of $79.1 million. This...

Continue Reading
Avenue Living Secures Major Growth Milestone with Unencumbered Assets

Updated Category News Views 254

Avenue Living Achieves Significant Milestone in Unencumbered Assets Calgary-based Avenue Living has hit a remarkable benchmark in its capital management strategy by amassing nearly $800 million in unencumbered assets. As one of North America's rapidly growing private real estate investment firms, this significant achievement positions Avenue Living at the forefront of the...

Continue Reading
In-Depth Analysis of Options Trading for Walt Disney Stock

Updated Category News Views 139

Strong Activity in Options Trading for Disney Recent movements in the options market highlight a strong bullish sentiment surrounding Walt Disney (NYSE: DIS). A thorough examination of options history reveals that institutional investors, often referred to as 'smart money,' are actively placing significant bets that point to an optimistic outlook for the company. Notably,...

Continue Reading